Jubrail Dahabreh
Athens, ESYE31 15125, Greece
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Simultaneous pathological findings in biopsy specimens of patients with surgically resected lung carcinoids and their role in survival.
Journal: Oncology letters
Published: April 26, 2022
Prognostic value of the immunohistochemistry markers CD56, TTF-1, synaptophysin, CEA, EMA and NSE in surgically resected lung carcinoid tumors.
Journal: Molecular and clinical oncology
Published: October 12, 2021
Efficacy of the MAGE-A3 cancer immunotherapeutic as adjuvant therapy in patients with resected MAGE-A3-positive non-small-cell lung cancer (MAGRIT): a randomised, double-blind, placebo-controlled, phase 3 trial.
Journal: The Lancet. Oncology
Published: November 09, 2015
Determination of EGFR and KRAS mutational status in Greek non-small-cell lung cancer patients.
Journal: Oncology letters
Published: September 12, 2014
Adjuvant MAGE-A3 immunotherapy in resected non-small-cell lung cancer: phase II randomized study results.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: May 30, 2013
hMSH2 and hMLH1 gene expression patterns differ between lung adenocarcinoma and squamous cell carcinoma: correlation with patient survival and response to adjuvant chemotherapy treatment.
Journal: The International journal of biological markers
Published: July 04, 2012
Showing 1-8 of 8
Last Updated: 09/26/2026